Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Judith Feucht, Kathrin Opherk, Peter Lang, Simone Kayser, Lena Hartl, Wolfgang Bethge, Susanne Matthes-Martin, Peter Bader, Michael H. Albert, Britta Maecker-Kolhoff, Johann Greil, Hermann Einsele, Paul-Gerhardt Schlegel, Friedhelm R. Schuster, Bernhard Kremens, Claudia Rossig, Bernd Gruhn, Rupert Handgretinger, Tobias Feuchtinger

Blood (2015) 125 (12): 1986–1994.

https://doi.org/10.1182/blood-2014-06-573725

Published: 2015

Includes: Supplemental data

Journal Articles

Detection of Th1 Driven T-Cell Responses in Peripheral Could Guide Individualized Immunosuppression and Risk of Viral Reactivation Under GvHD Prophylaxis Following Allogeneic Stem Cell Transplantation.

Judith Feucht, Kathrin Opherk, Cornelia Neinhaus, Simone Kayser, Wolfgang A. Bethge, MD, Rupert Handgretinger, MD, Peter Lang, MD, Tobias F. Feuchtinger, MD

Blood (2012) 120 (21): 3047.

https://doi.org/10.1182/blood.V120.21.3047.3047

Published: 2012

Journal Articles

Transient but Reversible Activation Defect of T-Cell Responses Against Cytomegalovirus and Adenovirus through Immunosuppresion with Calcineurin Inhibitors.

Cornelia Neinhaus, Kathrin Opherk, Simone Kayser, Joseph Leibold, Judith Feucht, Peter Lang, Rupert Handgretinger, MD, PhD, Tobias F. Feuchtinger, MD

Blood (2010) 116 (21): 4542.

https://doi.org/10.1182/blood.V116.21.4542.4542

Published: 2010

Journal Articles

Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation

Vanya Icheva, Kathrin Opherk, Wolfgang A. Bethge, Simone Kayser, Johann Greil, MD, Rupert Handgretinger, MD, PhD, Peter Lang, Tobias F. Feuchtinger, MD

Blood (2010) 116 (21): 2342.

https://doi.org/10.1182/blood.V116.21.2342.2342

Published: 2010

Journal Articles

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Tobias Feuchtinger, Kathrin Opherk, Wolfgang A. Bethge, Max S. Topp, Friedhelm R. Schuster, Eva M. Weissinger, Mohamad Mohty, Reuven Or, Michael Maschan, Michael Schumm, Klaus Hamprecht, Rupert Handgretinger, Peter Lang, Hermann Einsele

Blood (2010) 116 (20): 4360–4367.

https://doi.org/10.1182/blood-2010-01-262089

Published: 2010

Journal Articles

Adoptive Transfer of Hexon-Specific T-Cells as a Treatment of Adenovirus Reactivation Following Allogeneic Stem Cell Transplantation.

Kathrin Opherk, Friedhelm R Schuster, MD, Wolfgang Andreas Bethge, MD, Peter Bader, Johann Greil, Gernot Stuhler, MD, Michael H Albert, MD, Martin G. Sauer, MD, Rupert Handgretinger, MD, Peter Lang, MD, Tobias Feuchtinger

Blood (2009) 114 (22): 796.

https://doi.org/10.1182/blood.V114.22.796.796

Published: 2009

NARROW

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Detection of Th1 Driven T-Cell Responses in Peripheral Could Guide Individualized Immunosuppression and Risk of Viral Reactivation Under GvHD Prophylaxis Following Allogeneic Stem Cell Transplantation.

Transient but Reversible Activation Defect of T-Cell Responses Against Cytomegalovirus and Adenovirus through Immunosuppresion with Calcineurin Inhibitors.

Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Adoptive Transfer of Hexon-Specific T-Cells as a Treatment of Adenovirus Reactivation Following Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

Detection of Th1 Driven T-Cell Responses in Peripheral Could Guide Individualized Immunosuppression and Risk of Viral Reactivation Under GvHD Prophylaxis Following Allogeneic Stem Cell Transplantation.

Transient but Reversible Activation Defect of T-Cell Responses Against Cytomegalovirus and Adenovirus through Immunosuppresion with Calcineurin Inhibitors.

Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

Adoptive Transfer of Hexon-Specific T-Cells as a Treatment of Adenovirus Reactivation Following Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only